E
Eduardo Anitua
Researcher at University of the Basque Country
Publications - 346
Citations - 16253
Eduardo Anitua is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Implant & Medicine. The author has an hindex of 54, co-authored 295 publications receiving 14093 citations. Previous affiliations of Eduardo Anitua include Leonardo & University of Milan.
Papers
More filters
Journal ArticleDOI
Autologous platelets as a source of proteins for healing and tissue regeneration
TL;DR: The aim is to discuss the ways in which platelets may provide such unexpected beneficial therapeutic effects in clinical situations requiring rapid healing and tissue regeneration.
Journal Article
Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.
TL;DR: Preliminary clinical evidence is presented of the beneficial effect of the use of plasma rich in growth factors of autologous origin, which can introduce several advantages, including the enhancement and acceleration of bone regeneration and more rapid and predictable soft tissue healing.
Journal ArticleDOI
Comparison of Surgically Repaired Achilles Tendon Tears Using Platelet-Rich Fibrin Matrices
TL;DR: The operative management of tendons combined with the application of autologous PRGF may present new possibilities for enhanced healing and functional recovery in patients affected by musculoskeletal traumatic injuries.
Journal ArticleDOI
Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.
Eduardo Anitua,Isabel Andia,Mikel Sánchez,Juan Azofra,M del Mar Zalduendo,Maria de la Fuente,Paquita Nurden,Alan T. Nurden +7 more
TL;DR: It is suggested that administering autologous platelet‐rich clots may be beneficial to the treatment of tendon injuries by inducing cell proliferation and promoting the synthesis of angiogenic factors during the healing process.
Journal ArticleDOI
New insights into and novel applications for platelet-rich fibrin therapies
TL;DR: The therapeutic use of autologous platelet-rich plasma is highlighted and some of the obstacles and challenges that need to be addressed to maintain progress in this field are discussed.